Effect of the use of vital dye, lymphoscintigraphy, or a combination for axillary lymphatic mapping and sentinel node biopsy in breast cancer

World Journal of Surgery

Volumn 26, Issue 5, 2002, Pages 588-590

  D'Eredita, Giovanni ^a   Serio, Gabriella ^a   Mele, Marino ^a   Giardina, Carmela ^a   Martellotta, Martino ^a   Ferrarese, Filippo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MORBIDITY; PREDICTION; RELIABILITY; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; VITAL STAIN; AXILLA; BREAST TUMOR; EVALUATION; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

COLORING AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0041488891     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0272-4     Document Type: Article

References (12)

1. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J.A.M.A. 1996;276:1818-1822
2. Morton D, Wen D, Cochran A. Management of early-stage melanoma by operative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait.". Surg. Oncol. Clin. North Am. 1992;1:247-259
3. Van der Veen H, Hoekstra OS, Paul MA, et al. Gamma-probe-guided sentinel node biopsy to select patients with melanoma for limphadenectomy. Br. J. Surg. 1994;81:1769-1770
4. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994;220:391-401
5. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary metastases by level of invasion: an analysis of 539 cases. Cancer 1978;15:682-687
6. Hsu SM, Raine L, Fauger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP procedures). J. Histochem. Cytochem. 1981;29:577-580
7. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994;220:391-401
8. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J. Am. Coll. Surg. 1999;188:248-254
9. Veronesi U, Zurrida S, Galimberti V. Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies. Eur. J. Surg. Oncol. 1998;24:93-95
10. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience al Memorial Sloan-Kettering Cancer Center. J. Am. Coll. Surg. 1998;186:423-427
11. Cody HS III, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg. Oncol. 1999;8:85-91
12. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann. Surg. 1998;227:645-653